Previous studies have shown that genetic loss of Slc6a19 in mice recapitulates the phenotype observed in Hartnup disorder, characterized by increased urinary excretion of amino acids, including Phe, without causing a pathological decrease in plasma amino acid levels (20, 21). Here, SLC6A19 is linked to Hartnup disease.